Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)	Common stock	Additional paid-in capital	Accumulated deficit	Total
Balance at Dec. 31, 2020	$ 31	$ 6,431,715	$ (10,647,844)	$ (4,216,098)
Balance (in Shares) at Dec. 31, 2020	3,145,153
Common stock issued pursuant to initial public offering, net of offering costs	$ 18	15,783,189		15,783,207
Common stock issued pursuant to initial public offering, net of offering costs (in Shares)	1,800,000
Common stock issued pursuant to underwritten public offering, net of offering costs	$ 67	36,999,398		36,999,465
Common stock issued pursuant to underwritten public offering, net of offering costs (in Shares)	6,670,000
Cashless exercise of stock options and warrants
Cashless exercise of stock options and warrants (in Shares)	85,669
Stock-based compensation		974,234		974,234
Restricted stock awards granted	$ 1	(1)
Restricted stock awards granted (in Shares)	15,000
Restricted stock awards forfeited
Restricted stock awards forfeited (in Shares)	(937)			937
Net loss			(12,056,063)	$ (12,056,063)
Balance at Dec. 31, 2021	$ 117	60,188,535	(22,703,907)	37,484,745
Balance (in Shares) at Dec. 31, 2021	11,714,885
Stock-based compensation		745,034		745,034
Restricted stock awards forfeited
Restricted stock awards forfeited (in Shares)	(601)			601
Net loss			(21,650,720)	$ (21,650,720)
Balance at Dec. 31, 2022	$ 117	$ 60,933,569	$ (44,354,627)	$ 16,579,059
Balance (in Shares) at Dec. 31, 2022	11,714,284